Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis
Yih-Ting Chen, Shih‐Chieh Shao, Edward Chia‐Cheng Lai, Ming‐Jui Hung, Yung-Chang Chen
Abstract
Acute kidney injury (AKI), a predictor for poor clinical outcomes, has been reported as a severe complication of different coronavirus infections, including novel coronavirus disease 2019 (COVID-19) COVID-19 is considered more contagious than previous coronavirus infections, e.g., severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) [2], but comparisons of mortality rates from AKI among these three coronavirus infections remain uninvestigated. We therefore conducted a systematic review and meta-analysis comparing the mortality rate in patients with SARS, MERS, and COVID-19 who developed AKI.
Topics & Concepts
MedicineAcute kidney injurySevere acute respiratory syndromeMortality rateCoronavirus disease 2019 (COVID-19)Middle East respiratory syndromeCoronavirusIntensive care medicineMeta-analysisCohort studyMiddle East respiratory syndrome coronavirusInternal medicineSystematic reviewObservational studyMEDLINEEmergency medicineDiseaseInfectious disease (medical specialty)LawPolitical scienceCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesAcute Kidney Injury Research